1 – 7 of 7
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Acoustic Enrichment of Heterogeneous Circulating Tumor Cells and Clusters from Metastatic Prostate Cancer Patients
(
- Contribution to journal › Article
- 2023
-
Mark
Acoustic enrichment of heterogenous circulating tumor cells and clusters from patients with metastatic prostate cancer
2023)(
- Working paper/Preprint › Preprint in preprint archive
-
Mark
Acoustophoresis enriches tumor cell clusters in blood of patients with prostate cancer
2023) Acoustofluidics Conference 2023, St. Louis USA(
- Contribution to conference › Abstract
- 2022
-
Mark
A Phase 2 Trial of the Effect of Antiandrogen Therapy on COVID-19 Outcome : No Evidence of Benefit, Supported by Epidemiology and In Vitro Data
(
- Contribution to journal › Article
- 2021
-
Mark
COVIDENZA - A prospective, multicenter, randomized PHASE II clinical trial of enzalutamide treatment to decrease the morbidity in patients with Corona virus disease 2019 (COVID-19) : a structured summary of a study protocol for a randomised controlled trial
(
- Contribution to journal › Letter
- 2017
-
Mark
Circulating Tumor Cells as a Marker for Progression-free Survival in Metastatic Castration-naïve Prostate Cancer
(
- Contribution to journal › Article
- 2012
-
Mark
Inhibition of metastasis in a castration resistant prostate cancer model by the quinoline-3-carboxamide tasquinimod (ABR-215050)
(
- Contribution to journal › Article